Ginkgo Bioworks
DNA
#7337
Rank
A$0.56 B
Marketcap
$9.73
Share price
-7.13%
Change (1 day)
-86.33%
Change (1 year)

Operating Margin for Ginkgo Bioworks (DNA)

Operating Margin as of March 2025 (TTM): -241.10%

According to Ginkgo Bioworks 's latest financial reports and stock price the company's current Operating Margin is -241.10%. At the end of 2024 the company had an Operating Margin of -241.15%.

Operating Margin history for Ginkgo Bioworks from 2021 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2024-241.15%-32.09%
2023-355.11%-20.03%
2022-444.08%-24.18%
2021-585.69%259.66%
2020-162.85%-26.37%
2019-221.16%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.